BDBM306721 3-fluoro-N-(2-((5-((1R,3R)-2-((3-fluorooxetan-3-yl)methyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-4-methoxypyridin-2-yl)oxy)ethyl)propan-1-amine::US10149839, Example 7

SMILES COc1cc(OCCNCCCF)ncc1[C@H]1N(CC2(F)COC2)[C@H](C)Cc2c1[nH]c1ccccc21

InChI Key InChIKey=BIZMOBPBOCNBHF-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 306721   

TargetEstrogen receptor(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 306721BDBM306721(US10149839, Example 7 | 3-fluoro-N-(2-((5-((1R,3R)...)
Affinity DataIC50: 2.10nMAssay Description:Compounds were dosed directly from a compound source microplate containing serially diluted compound (4 wells containing 10 mM, 0.1 mM, 1 mM and 10 n...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent